Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Post Traumatic Stress Disorder by Early Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Adults survivors of traumatic events~Exclusion Criteria:~* Traumatic brain injury~* Lifetime psychosis~* Life time (prior) PTSD~* Medical conditions forbidding SSRIs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Prolonged Exposure (CBT) (Type: EXPERIMENTAL): Twelve 1.5 hours weekly sessions of Prolonged Exposure cognitive behavioral therapy
- Cognitive Therapy (Type: ACTIVE_COMPARATOR): Twelve 1.5 hours weekly sessions of Cognitive Therapy without exposure to traumatic reminders.
- SSRI (escitalopram) (Type: EXPERIMENTAL): Twenty milligrams daily of escitalopram (blinded capsules)
- Placebo (Type: PLACEBO_COMPARATOR): Two concealed placebo pills resembling 10mg escitalopram tablets
- Waiting List (Type: NO_INTERVENTION): Twelve weeks of waiting list no intervention group

Based on this trial design, predict the completion outcome and termination type (if applicable).